BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 25155418)

  • 1. Indication for neoadjuvant chemotherapy in patients with colorectal liver metastases based on a nomogram that predicts disease-free survival.
    Okuno M; Hatano E; Seo S; Taura K; Yasuchika K; Nakajima A; Yazawa T; Furuyama H; Kawamoto H; Yagi S; Nishitai R; Fujikawa T; Arimoto A; Zaima M; Yoshimura T; Terajima H; Kaihara S; Manaka D; Tanaka A; Uemoto S
    J Hepatobiliary Pancreat Sci; 2014 Dec; 21(12):881-8. PubMed ID: 25155418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nomogram predicted disease free survival for colorectal liver metastasis patients with preoperative chemotherapy followed by hepatic resection.
    Liu W; Wang K; Han Y; Liang JY; Li YH; Xing BC
    Eur J Surg Oncol; 2019 Nov; 45(11):2070-2077. PubMed ID: 31279595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nomogram for prediction of prognosis in patients with initially unresectable colorectal liver metastases.
    Imai K; Allard MA; Castro Benitez C; Vibert E; Sa Cunha A; Cherqui D; Castaing D; Bismuth H; Baba H; Adam R
    Br J Surg; 2016 Apr; 103(5):590-9. PubMed ID: 26780341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiologic and pathologic response to neoadjuvant chemotherapy predicts survival in patients undergoing the liver-first approach for synchronous colorectal liver metastases.
    Berardi G; De Man M; Laurent S; Smeets P; Tomassini F; Ariotti R; Hoorens A; van Dorpe J; Varin O; Geboes K; Troisi RI
    Eur J Surg Oncol; 2018 Jul; 44(7):1069-1077. PubMed ID: 29615295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A nomogram predicting disease-free survival in patients with colorectal liver metastases treated with hepatic resection: multicenter data collection as a Project Study for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery.
    Beppu T; Sakamoto Y; Hasegawa K; Honda G; Tanaka K; Kotera Y; Nitta H; Yoshidome H; Hatano E; Ueno M; Takamura H; Baba H; Kosuge T; Kokudo N; Takahashi K; Endo I; Wakabayashi G; Miyazaki M; Uemoto S; Ohta T; Kikuchi K; Yamaue H; Yamamoto M; Takada T
    J Hepatobiliary Pancreat Sci; 2012 Jan; 19(1):72-84. PubMed ID: 22020927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response to chemotherapy predicts survival following resection of hepatic colo-rectal metastases in patients treated with neoadjuvant therapy.
    Small RM; Lubezky N; Shmueli E; Figer A; Aderka D; Nakache R; Klausner JM; Ben-Haim M
    J Surg Oncol; 2009 Feb; 99(2):93-8. PubMed ID: 19065637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does neoadjuvant chemotherapy reveal disease precluding surgical treatment of initially resectable colorectal cancer liver metastases?
    Reddy SK; Tsung A; Marsh JW; Geller DA
    J Surg Oncol; 2012 Jan; 105(1):55-9. PubMed ID: 21842519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CALy Prognostic Score (CEA, ALP, Lymphocyte Count) as a predictor of survival after hepatectomy for liver-only colorectal metastases.
    Neofytou K; Giakoustidis A; Mudan S
    J BUON; 2015; 20(3):746-55. PubMed ID: 26214626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simple tumor load-based nomogram for surgery in patients with colorectal liver and peritoneal metastases.
    Elias D; Faron M; Goéré D; Dumont F; Honoré C; Boige V; Malka D; Ducreux M
    Ann Surg Oncol; 2014 Jun; 21(6):2052-8. PubMed ID: 24499829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of adjuvant therapy after resection of colorectal cancer liver metastases.
    Power DG; Kemeny NE
    J Clin Oncol; 2010 May; 28(13):2300-9. PubMed ID: 20368552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors for disease-free survival after preoperative chemotherapy followed by curative resection in patients with colorectal cancer harboring hepatic metastasis: a single-institute, retrospective analysis in Asia.
    Yi JH; Kim H; Jung M; Shin SJ; Choi JS; Choi GH; Baik SH; Min BS; Kim NK; Ahn JB
    Oncology; 2013; 85(5):283-9. PubMed ID: 24217184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The safety and efficacy of neoadjuvant chemotherapy for patients with hepatic colorectal cancer metastases].
    Miyamoto A; Nakamori S; Tsujie M; Kurokawa Y; Yasui M; Ikenaga M; Miyazaki M; Hirao M; Fujitani K; Mishima H; Tsujinaka T
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2022-4. PubMed ID: 20037311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant chemotherapy and resection for initially irresectable colorectal liver metastases.
    Capussotti L; Muratore A; Mulas MM; Massucco P; Aglietta M
    Br J Surg; 2006 Aug; 93(8):1001-6. PubMed ID: 16739103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of margin status and neoadjuvant chemotherapy on survival, recurrence after liver resection for colorectal liver metastasis.
    Pandanaboyana S; White A; Pathak S; Hidalgo EL; Toogood G; Lodge JP; Prasad KR
    Ann Surg Oncol; 2015 Jan; 22(1):173-9. PubMed ID: 25084766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A critical appraisal of the role of neoadjuvant chemotherapy for colorectal liver metastases: a case-controlled study.
    Malik HZ; Farid S; Al-Mukthar A; Anthoney A; Toogood GJ; Lodge JP; Prasad KR
    Ann Surg Oncol; 2007 Dec; 14(12):3519-26. PubMed ID: 17912590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatic resection after neoadjuvant therapy for initially unresectable colorectal liver metastases].
    Kaibori M; Iwamoto S; Ishizaki M; Matsui K; Saito T; Yoshioka K; Kwon AH
    Gan To Kagaku Ryoho; 2009 Dec; 36(13):2579-82. PubMed ID: 20009458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of survival after liver resection for metastatic colorectal carcinoma.
    Parau A; Todor N; Vlad L
    J BUON; 2015; 20(1):68-77. PubMed ID: 25778299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction and validation of "WCH-nomogram" for predicting the prognosis after resection of colorectal liver metastases.
    Jiang C; Liu W; Jin Z; Lan L; Xu L; Du A; Peng S; Zeng Y; Wang H; Liao M; Zhou J
    Cancer Med; 2024 May; 13(9):e7222. PubMed ID: 38698687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrence-risk stratification using the Beppu score and selection of perioperative chemotherapy for colorectal liver metastases.
    Beppu T; Yamamura K; Imai K; Hayashi H; Miyamoto Y
    J Surg Oncol; 2024 Apr; 129(5):893-900. PubMed ID: 38239092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical relevance of the Fong and the Nordlinger scores in the era of effective neoadjuvant chemotherapy for colorectal liver metastasis.
    Schreckenbach T; Malkomes P; Bechstein WO; Woeste G; Schnitzbauer AA; Ulrich F
    Surg Today; 2015 Dec; 45(12):1527-34. PubMed ID: 25563588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.